课题基金 / 基金详情

Human cytomegalovirus: changes in the latently infected cell as chemotherapeutic and immunological targets for antiviral therapy

Human cytomegalovirus: changes in the latently infected cell as chemotherapeutic and immunological targets for antiviral therapy
人类巨细胞病毒:潜伏感染细胞的变化作为抗病毒治疗的化疗和免疫靶标
批准号:
MR/K021087/1
负责人:
John Sinclair
金额:
$203.5万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2013
资助国家:
英国
项目状态:
已结题
起止时间:
2013 至 --

项目摘要

项目成果

John Sinclair的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Human cytomegalovirus (HCMV) is a type of herpesvirus which is carried without symptoms by the majority of the population. However, it can cause serious disease in infants born to mothers who acquire the infection in pregnancy and in people whose immune systems are suppressed, for instance when they undergo transplantation for an organ such as a kidney or bone marrow it can be life threatening. The fact that up to 3 people are dying a day because of a lack of a suitable transplant organs and this is resulting in a call for increases in the number of transplants in the UK (http://www.bbc.co.uk/news/health-11688102), HCMV disease is likely to become more and more of a problem in transplant patients.Unlike many other viruses, HCMV is never cleared after its initial infection but persists for the life time of the individual. At least in part, this is due to the ability of HCMV to avoid the immune system by expression of virus genes which help it avoid immune responses. However, the lifelong persistence of this virus is also a biological property of all herpesviruses because the virus is able to undergo a so-called latent infection, where the virus hides in the cell without making new virus particles but is still able to reawaken, generating new infectious virtues which can cause disease and can also be passed on to other uninfected people. Understanding how the virus succeeds in maintaining itself in most people without causing disease and how this relationship breaks down to cause disease should help develop better methods of treating the virus and for designing a vaccine (there is currently no vaccine available).Our research is aimed at determining (i) the mechanism by which the virus maintains a silent infection (latency) in specialised cells of the immune system and how these help the virus reawaken (reactivation) and (ii) how the immune system is prevented from eliminating the virus from the body.In addition to advancing our understanding of HCMV, in particular, this research may also lead to a better understanding of other virus infections which persist in the body, how the human host controls and help identify common strategies for their elimination.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Cytomegalovirus and Cardiovascular Disease: A Hypothetical Role for Viral G-Protein-Coupled Receptors in Hypertension.
巨细胞病毒和心血管疾病:病毒 G 蛋白偶联受体在高血压中的假设作用。
DOI: 10.17863/cam.104198
发表时间: 2023
期刊:
影响因子: --
作者: [Bomfim G]
通讯作者: Bomfim G
DOI: 10.1128/jvi.02614-15
发表时间: 2016-01-06
期刊: Journal of virology
影响因子: 5.4
作者: [Chen KC, Stanton RJ, Banat JJ, Wills MR]
通讯作者: Wills MR
DOI: 10.1126/science.aam9243
发表时间: 2017-07-07
期刊: Science (New York, N.Y.)
影响因子: --
作者: [Chavali PL, Stojic L, Meredith LW, Joseph N, Nahorski MS, Sanford TJ, Sweeney TR, Krishna BA, Hosmillo M, Firth AE, Bayliss R, Marcelis CL, Lindsay S, Goodfellow I, Woods CG, Gergely F]
通讯作者: Gergely F
DOI: 10.1088/1748-0221/15/12/p12037
发表时间: 2020-12-01
期刊: JOURNAL OF INSTRUMENTATION
影响因子: 1.3
作者: [Abratenko, P., Alrashed, M., Zhang, C.]
通讯作者: Zhang, C.
Understanding human cytomegalovirus latency as a means to target the latent reservoir
  • 批准号:
    MR/S00081X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $237.56万
  • 财政年份:
    2018
  • 负责人:
    John Sinclair
  • 依托单位:
Human cytomegalovirus latency, reactivation and immune control
  • 批准号:
    G0701279/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $213.93万
  • 财政年份:
    2008
  • 负责人:
    John Sinclair
  • 依托单位:
海外基金